LIDOCAINE Side Effects

7012114-0 | Ischaemia
on Sep 15, 2010 Male patient from KOREA, REPUBLIC OF , 36 years of age, was diagnosed with nerve block and was treated with Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: ischaemia. Lidocaine dosage: . Patient was hospitalized.

7010355-X | Arteriospasm Coronary, Blood Pressure Increased, Cardiac Arrest, Cardiac Enzymes Increased, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram St Segment Elevation, Electrocardiogram T Wave Inversion, Heart Rate Increased, Prinzmetal Angina
Patient was taking Lidocaine (View Usage). Patient had the following side effects: arteriospasm coronary, blood pressure increased, cardiac arrest (What is cardiac arrest?), cardiac enzymes increased, electrocardiogram qrs complex prolonged, electrocardiogram st segment elevation, electrocardiogram t wave inversion, heart rate increased, prinzmetal angina on Sep 22, 2010 from Additional patient health information: Male patient , 35 years of age, weighting 154.3 lb, was diagnosed with anaesthesia, resuscitation, electrocardiogram abnormal, maintenance of anaesthesia and. Lidocaine dosage: 7.5 Ml. During the same period patient was treated with DESFLURANE (View Desflurane Review and Desflurane Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), MAGNESIUM SULFATE (1 G) (View Magnesium Sulfate Review and Magnesium Sulfate Label ).

7007507-1 | Epilepsy
Adverse event was reported on Sep 13, 2010 by a Female patient taking Lidocaine (View Usage) (Dosage: ) was diagnosed with glossitis and. Location: GERMANY , 41 years of age, weighting 138.9 lb, After Lidocaine was administered, patient had the following side effects: epilepsy (What is epilepsy?).

6988788-7 | Blister, Erythema, Pain, Skin Necrosis, Swelling, Syncope
on Sep 14, 2010 Female patient from , 81 years of age, was diagnosed with application site anaesthesia and was treated with Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: blister, erythema, pain (What is pain?), skin necrosis, swelling, syncope. Lidocaine dosage: 3 Ml. During the same period patient was treated with EPINEPHRINE (View Epinephrine Review and Epinephrine Label ).


6984821-7 | Diplopia, Vith Nerve Paralysis
on Sep 13, 2010 Female patient from , 32 years of age, was diagnosed with nerve block and was treated with Lidocaine (View Usage). Patient had the following side effects: diplopia, vith nerve paralysis. Lidocaine dosage: . During the same period patient was treated with EPINEPHRINE (View Epinephrine Review and Epinephrine Label ).

6944741-0 | Epilepsy
Patient was taking Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: epilepsy (What is epilepsy?) on Aug 18, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 37 years of age, was diagnosed with local anaesthesia and. Lidocaine dosage: .

6940368-5 | Conjunctival Haemorrhage, Corneal Disorder, Corneal Oedema, Injection Site Haemorrhage, Ocular Toxicity
Adverse event was reported on Aug 23, 2010 by a Male patient taking Lidocaine (View Usage) (Dosage: ) was diagnosed with local anaesthesia and. Location: , 72 years of age, Patient experienced the following unwanted or unexpected effects: conjunctival haemorrhage, corneal disorder, corneal oedema, injection site haemorrhage, ocular toxicity. During the same period patient was treated with BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ).

6923159-0 | Skin Necrosis, Syncope
on Aug 05, 2010 Female patient from TUNISIA , 81 years of age, was diagnosed with local anaesthesia and was treated with Lidocaine (View Usage). Patient had the following side effects: skin necrosis, syncope. Lidocaine dosage: .

6923158-9 | Skin Necrosis, Syncope
on Aug 05, 2010 Female patient from TUNISIA , 74 years of age, was diagnosed with local anaesthesia and was treated with Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: skin necrosis, syncope. Lidocaine dosage: .

6882375-7 | Anaphylactic Reaction
Patient was taking Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction on Jul 28, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 223.3 lb, . Lidocaine dosage: . Patient was hospitalized.

6870977-3 | Application Site Erythema, Application Site Pain
Adverse event was reported on Jul 16, 2010 by a Male patient taking Lidocaine (View Usage) (Dosage: ) was diagnosed with pain (What is pain?), mineral supplementation, deep vein thrombosis (What is deep vein thrombosis?), constipation (What is constipation?) and. Location: UNITED KINGDOM , 70 years of age, Patient had the following side effects: application site erythema, application site pain. During the same period patient was treated with BUPRENORPHINE (View Buprenorphine Review and Buprenorphine Label ), CALCICHEW D3 (View Calcichew D3 Review and Calcichew D3 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), NULYTELY (View Nulytely Review and Nulytely Label ).

6855897-2 | Cardiac Arrest
on Jul 13, 2010 Female patient from BRAZIL , 60 years of age, was diagnosed with local anaesthesia and was treated with Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). Lidocaine dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ).

6855893-5 | Cardiac Arrest
on Jul 13, 2010 Female patient from BRAZIL , 51 years of age, was diagnosed with local anaesthesia and was treated with Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). Lidocaine dosage: 32 Ug/ml. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ).

6848570-8 | Bronchospasm, Hypoventilation, Loss Of Consciousness, Oxygen Saturation Decreased, Respiratory Depression, Wheezing
Patient was taking Lidocaine (View Usage). Patient had the following side effects: bronchospasm, hypoventilation, loss of consciousness, oxygen saturation decreased, respiratory depression, wheezing on Jul 15, 2010 from Additional patient health information: Male patient , 72 years of age, was diagnosed with local anaesthesia and. Lidocaine dosage: . During the same period patient was treated with BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ), HYALURONIDASE (View Hyaluronidase Review and Hyaluronidase Label ), ATROPINE (0.8 Mg) (View Atropine Review and Atropine Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUCCINYLCHOLINE (View Succinylcholine Review and Succinylcholine Label ).

6786767-6 | Cardiac Arrest, Sinus Tachycardia, Ventricular Extrasystoles
Adverse event was reported on Jun 21, 2010 by a Male patient taking Lidocaine (View Usage) (Dosage: ) was diagnosed with local anaesthesia, sedation and. Location: , 26 years of age, weighting 132.3 lb, After Lidocaine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), sinus tachycardia, ventricular extrasystoles. During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), ATROPINE (View Atropine Review and Atropine Label ), PENTAZOCINE (View Pentazocine Review and Pentazocine Label ). Patient was hospitalized.

6753699-9 |
on May 31, 2010 Female patient from BRAZIL , 15 years of age, was diagnosed with local anaesthesia and was treated with Lidocaine (View Usage). . Lidocaine dosage: . During the same period patient was treated with COMPAZ (View Compaz Review and Compaz Label ). Patient was hospitalized.

6752902-9 | Feeling Abnormal, Flushing, Heart Rate Increased, Latex Allergy
on Jun 02, 2010 Female patient from UNITED STATES , 69 years of age, was diagnosed with joint injection and was treated with Lidocaine (View Usage). Patient had the following side effects: feeling abnormal, flushing, heart rate increased, latex allergy (What is latex allergy?). Lidocaine dosage: 5 Ml Once Im.

6749542-4 | Confusional State, Cyanosis, Disorientation, Dizziness, Feeling Drunk, Left Ventricular Hypertrophy, Palpitations
Patient was taking Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: confusional state, cyanosis, disorientation, dizziness (What is dizziness?), feeling drunk, left ventricular hypertrophy, palpitations on May 20, 2010 from UNITED STATES Additional patient health information: Male patient , 50 years of age, was diagnosed with infusion related reaction and. Lidocaine dosage: 80 Ml Of Undiluted Two Percent Viscous Lidocaine (16 Mg/kg). Patient was hospitalized.

6743303-8 | Nausea
Adverse event was reported on May 19, 2010 by a Female patient taking Lidocaine (View Usage) (Dosage: ) was diagnosed with local anaesthesia and. Location: BRAZIL , 43 years of age, Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?). During the same period patient was treated with COMPAZ (View Compaz Review and Compaz Label ). Patient was hospitalized.

6743249-5 | Nausea
on May 19, 2010 Male patient from BRAZIL , 27 years of age, was diagnosed with local anaesthesia and was treated with Lidocaine (View Usage). Patient had the following side effects: nausea (What is nausea?). Lidocaine dosage: . During the same period patient was treated with COMPAZ (View Compaz Review and Compaz Label ). Patient was hospitalized.

6743247-1 | Nausea
on May 19, 2010 Female patient from BRAZIL , 36 years of age, was diagnosed with local anaesthesia and was treated with Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: nausea (What is nausea?). Lidocaine dosage: . During the same period patient was treated with COMPAZ (View Compaz Review and Compaz Label ).

6743240-9 | Nausea
Patient was taking Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?) on May 19, 2010 from BRAZIL Additional patient health information: Female patient , 63 years of age, was diagnosed with local anaesthesia and. Lidocaine dosage: . During the same period patient was treated with COMPAZ (View Compaz Review and Compaz Label ). Patient was hospitalized.

6737652-7 | Cardiac Arrest
Adverse event was reported on May 18, 2010 by a Female patient taking Lidocaine (View Usage) (Dosage: ) was diagnosed with local anaesthesia and. Location: BRAZIL , 60 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?). During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ).

6737650-3 | Cardiac Arrest
on May 18, 2010 Female patient from BRAZIL , 51 years of age, was diagnosed with local anaesthesia and was treated with Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). Lidocaine dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ).

6732641-0 | Cardiac Arrest, Heart Rate Increased, Mean Arterial Pressure Decreased, Ventricular Fibrillation
on May 17, 2010 Female patient from , 51 years of age, weighting 125.7 lb, was diagnosed with local anaesthesia, induction of anaesthesia, induction and maintenance of anaesthesia, neuromuscular blockade and was treated with Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), heart rate increased, mean arterial pressure decreased, ventricular fibrillation. Lidocaine dosage: 18 Ml. During the same period patient was treated with PROPOFOL (150 Mg) (View Propofol Review and Propofol Label ), FENTANYL (0.2 Mg) (View Fentanyl Review and Fentanyl Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), EPINEPHRINE (90 Mcg) (View Epinephrine Review and Epinephrine Label ).

6711647-1 | Anaesthesia
Patient was taking Lidocaine (View Usage). Patient had the following side effects: anaesthesia on May 04, 2010 from Additional patient health information: Male patient , 68 years of age, was diagnosed with nerve block and. Lidocaine dosage: . During the same period patient was treated with BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ), HYALURONIDASE (View Hyaluronidase Review and Hyaluronidase Label ).

6709169-7 | Product Container Seal Issue, Product Packaging Quantity Issue
Adverse event was reported on Apr 23, 2010 by a Male patient taking Lidocaine (View Usage) (Dosage: ) was diagnosed with pain (What is pain?), hypoaesthesia and. Location: , weighting 220.5 lb, After Lidocaine was administered, patient had the following side effects: product container seal issue, product packaging quantity issue. During the same period patient was treated with ORAJEL (View Orajel Review and Orajel Label ), ANBESOL GEL (View Anbesol Gel Review and Anbesol Gel Label ), HYDROCODONE BITARTRATE (10 Mg) (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ).

6663406-6 | Bronchospasm, Oxygen Saturation Decreased
on Mar 30, 2010 Female patient from , 35 years of age, was diagnosed with nerve block, local anaesthesia, induction of anaesthesia, maintenance of anaesthesia and was treated with Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, oxygen saturation decreased. Lidocaine dosage: 8 Ml. During the same period patient was treated with HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

6645448-X | Anaphylactic Reaction
on Mar 18, 2010 Male patient from UNITED KINGDOM , 65 years of age, weighting 165.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), myocardial ischaemia and was treated with Lidocaine (View Usage). Patient had the following side effects: anaphylactic reaction. Lidocaine dosage: . During the same period patient was treated with DEPO MEDROL (View Depo-medrol Review and Depo-medrol Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), MONOMIL XL (View Monomil Xl Review and Monomil Xl Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), STATIN NOS (View Statin Nos Review and Statin Nos Label ).

6635703-1 | Bradycardia, Dyspnoea, Hypotension
Patient was taking Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: bradycardia, dyspnoea, hypotension on Mar 12, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Lidocaine dosage: 150 Mg Once Iv. Patient was hospitalized.

6635694-3 | Procedural Pain, Therapeutic Response Decreased
Adverse event was reported on Mar 12, 2010 by a Male patient taking Lidocaine (View Usage) (Dosage: 3.5 Ml Once Other) was diagnosed with cataract operation and. Location: UNITED STATES , 79 years of age, weighting 156.1 lb, Patient experienced the following unwanted or unexpected effects: procedural pain, therapeutic response decreased.

6635693-1 | Procedural Pain, Therapeutic Response Decreased
on Mar 12, 2010 Male patient from UNITED STATES , 69 years of age, weighting 205.9 lb, was diagnosed with cataract operation and was treated with Lidocaine (View Usage). Patient had the following side effects: procedural pain, therapeutic response decreased. Lidocaine dosage: 3.5 Ml Once Other.

6635692-X | Procedural Pain, Therapeutic Response Decreased
on Mar 12, 2010 Male patient from UNITED STATES , 73 years of age, weighting 203.9 lb, was diagnosed with cataract operation and was treated with Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: procedural pain, therapeutic response decreased. Lidocaine dosage: 3.5 Ml Once Other.

6635691-8 | Procedural Pain, Therapeutic Response Decreased
Patient was taking Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: procedural pain, therapeutic response decreased on Mar 12, 2010 from UNITED STATES Additional patient health information: Male patient , 88 years of age, weighting 119.5 lb, was diagnosed with cataract operation and. Lidocaine dosage: 3.5 Ml Once Other.

6635638-4 | Procedural Pain
Adverse event was reported on Mar 12, 2010 by a Male patient taking Lidocaine (View Usage) (Dosage: 3.5 Ml Once Other) was diagnosed with cataract (What is cataract?) and. Location: UNITED STATES , 74 years of age, weighting 151.5 lb, Patient had the following side effects: procedural pain.

6635635-9 | No Therapeutic Response, Procedural Pain
on Mar 12, 2010 Male patient from UNITED STATES , 73 years of age, weighting 158.1 lb, was diagnosed with cataract (What is cataract?), surgery (What is surgery?) and was treated with Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: no therapeutic response, procedural pain. Lidocaine dosage: 3.5 Ml Once Other.

6632749-4 | Muscle Spasms
on Mar 10, 2010 Male patient from , 36 years of age, weighting 176.4 lb, was diagnosed with muscle spasms, pain in extremity, thrombosis prophylaxis and was treated with Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: muscle spasms. Lidocaine dosage: . During the same period patient was treated with ADRENALINE (View Adrenaline Review and Adrenaline Label ), BUPIVACAINE HCL (20 Ml) (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ), BOTOX (View Botox Review and Botox Label ), CLEXANE (View Clexane Review and Clexane Label ).

6628262-0 | Anaphylactic Reaction
Patient was taking Lidocaine (View Usage). Patient had the following side effects: anaphylactic reaction on Mar 08, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 65 years of age, weighting 165.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), myocardial ischaemia and. Lidocaine dosage: . During the same period patient was treated with DEPO MEDROL (View Depo-medrol Review and Depo-medrol Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), MONOMIL XL (View Monomil Xl Review and Monomil Xl Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), STATIN NOS (View Statin Nos Review and Statin Nos Label ).

6606664-6 | Infection
Adverse event was reported on Feb 17, 2010 by a Female patient taking Lidocaine (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 18 years of age, weighting 192.9 lb, After Lidocaine was administered, patient had the following side effects: infection (What is infection?). During the same period patient was treated with IMPLANON (View Implanon Review and Implanon Label ).

6582662-6 | Anaphylactic Shock, Respiratory Failure
on Feb 12, 2010 Male patient from NORWAY , 67 years of age, was diagnosed with infiltration anaesthesia, antibiotic prophylaxis, infection prophylaxis and was treated with Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, respiratory failure. Lidocaine dosage: . During the same period patient was treated with DOXYCYCLINE (Dissolved In 1000 Ml Ringer Acetate Solution. Few Ml Administered Before Withdrawal.) (View Doxycycline Review and Doxycycline Label ), KLORHEXIDINSPRIT FRESENIUS KABI (View Klorhexidinsprit Fresenius Kabi Review and Klorhexidinsprit Fresenius Kabi Label ).

6576612-6 | Convulsion, Loss Of Consciousness
on Feb 03, 2010 Female patient from CANADA , child 6 years of age, was diagnosed with local anaesthesia and was treated with Lidocaine (View Usage). Patient had the following side effects: convulsion, loss of consciousness. Lidocaine dosage: .

6576573-X | Coma, Convulsion, Hypertension, Somnolence
Patient was taking Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: coma, convulsion, hypertension, somnolence on Feb 03, 2010 from CANADA Additional patient health information: Male patient , 13 years of age, was diagnosed with anaesthesia and. Lidocaine dosage: .

6573595-X | Apnoea, Convulsion, Electrocardiogram Abnormal, Pulse Absent
Adverse event was reported on Feb 03, 2010 by a Female patient taking Lidocaine (View Usage) (Dosage: 6.3 Mg/kg, 0.6 Ml/kg Volume) was diagnosed with local anaesthesia and. Location: CANADA , 58 years of age, Patient experienced the following unwanted or unexpected effects: apnoea, convulsion, electrocardiogram abnormal, pulse absent. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ).

6573517-1 | Cardiac Arrest, Sinoatrial Block
on Feb 03, 2010 Male patient from CANADA , 26 years of age, was diagnosed with local anaesthesia and was treated with Lidocaine (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), sinoatrial block. Lidocaine dosage: 2.8 Mg/kg.

6568073-8 | Anaphylactic Shock, Anosmia, Laryngeal Oedema, Lip Oedema
on Jan 29, 2010 Male patient from , 19 years of age, weighting 101.4 lb, was diagnosed with local anaesthesia, endotracheal intubation, anaphylactic shock, hypotension and was treated with Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: anaphylactic shock, anosmia, laryngeal oedema, lip oedema. Lidocaine dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), HEPARIN (View Heparin Review and Heparin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), NORADRENALIN (View Noradrenalin Review and Noradrenalin Label ). Patient was hospitalized.

6565308-2 | Angioedema, Bronchospasm
Patient was taking Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, bronchospasm on Jan 27, 2010 from Additional patient health information: Female patient , 76 years of age, was diagnosed with skin test, aspiration pleural cavity, bronchospasm and. Lidocaine dosage: . During the same period patient was treated with PROCAINE HCL (View Procaine Hcl Review and Procaine Hcl Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6553810-9 | Disorientation, Feeling Abnormal, Headache, Hyperacusis, Tinnitus, Vertigo
Adverse event was reported on Jan 25, 2010 by a Female patient taking Lidocaine (View Usage) (Dosage: Iv 1 X For Surgery) was diagnosed with nephrolithiasis and. Location: UNITED STATES , 66 years of age, weighting 190.0 lb, Patient had the following side effects: disorientation, feeling abnormal, headache (What is headache?), hyperacusis, tinnitus (What is tinnitus?), vertigo. During the same period patient was treated with DIPRIVAN (Iv 1 X For Surgery) (View Diprivan Review and Diprivan Label ), PEPSID (View Pepsid Review and Pepsid Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), KEFLEX (View Keflex Review and Keflex Label ).

6550878-0 | Depression, Violence-related Symptom
on Jan 25, 2010 Male patient from , weighting 229.3 lb, was diagnosed with stomatitis, hepatitis c (What is hepatitis c?) and was treated with Lidocaine (View Usage). After Lidocaine was administered, patient had the following side effects: depression (What is depression?), violence-related symptom. Lidocaine dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), RIBAVIRIN (1200 Mg) (View Ribavirin Review and Ribavirin Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ).

6535273-2 | Toxic Anterior Segment Syndrome
on Jan 04, 2010 Female patient from UNITED KINGDOM , 81 years of age, was diagnosed with anaesthesia, cataract operation, eye irrigation, preoperative care, eye operation and was treated with Lidocaine (View Usage). Patient experienced the following unwanted or unexpected effects: toxic anterior segment syndrome. Lidocaine dosage: . During the same period patient was treated with ADRENALINE (View Adrenaline Review and Adrenaline Label ), BALANCED SALT (View Balanced Salt Review and Balanced Salt Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), CYCLOPENTOLATE HCL (View Cyclopentolate Hcl Review and Cyclopentolate Hcl Label ), FLURBIPROFEN SODIUM (View Flurbiprofen Sodium Review and Flurbiprofen Sodium Label ), HYALURONATE SODIUM (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ), NEOMYCIN (View Neomycin Review and Neomycin Label ).

6523013-2 | Atrial Fibrillation, Cardiac Disorder, Electrolyte Imbalance, Fluid Imbalance
Patient was taking Lidocaine (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac disorder, electrolyte imbalance, fluid imbalance on Dec 10, 2009 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 163.0 lb, . Lidocaine dosage: 40 Intravenous. During the same period patient was treated with PROPOFOL (250, Intravenous) (View Propofol Review and Propofol Label ), GOLYTELY /00747901/ (View Golytely /00747901/ Review and Golytely /00747901/ Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ). Patient was hospitalized.